Full View

Optimal first‐line treatment for advanced thymic carcinoma

X Yang, M Zhuo, A Shi, S Yang, Z Wang, M Wu… - Thoracic …, 2019 - Wiley Online Library
Background Thymic carcinomas (TCs) are rare aggressive tumors with no standard first‐line
treatment. This study was conducted to determine the optimal chemotherapy regimen for …
被引用次数：12 相关文章

Optimal first-line treatment for advanced thymic carcinoma.

X Yang, M Zhuo, A Shi, S Yang, Z Wang, M Wu… - Thoracic …, 2019 - europepmc.org
BACKGROUND: Thymic carcinomas (TCs) are rare aggressive tumors with no standard first-
line treatment. This study was conducted to determine the optimal chemotherapy regimen for …
[HTML] nih.gov

[HTML][HTML] Optimal first‐line treatment for advanced thymic carcinoma

X Yang, M Zhuo, A Shi, S Yang, Z Wang, M Wu… - Thoracic …, 2019 - ncbi.nlm.nih.gov
Background Thymic carcinomas (TCs) are rare aggressive tumors with no standard first‐line
treatment. This study was conducted to determine the optimal chemotherapy regimen for …

Optimal first-line treatment for advanced thymic carcinoma

X Yang, M Zhuo, A Shi, S Yang, Z Wang… - Thoracic …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Thymic carcinomas (TCs) are rare aggressive tumors with no standard first-line
treatment. This study was conducted to determine the optimal chemotherapy regimen for …

Optimal first‐line treatment for advanced thymic carcinoma

X Yang, M Zhuo, A Shi, S Yang, Z Wang… - Thoracic …, 2019 - search.proquest.com
Background Thymic carcinomas (TCs) are rare aggressive tumors with no standard first‐line
treatment. This study was conducted to determine the optimal chemotherapy regimen for …